L2U-84618-33650
3 vaccinations
5 coded responses
6 check-ins
5 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 064 / CT
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-03
Registered in v-safe
-
2021-03-03
Dose 1 — Pfizer-BioNTech
-
2021-03-31
Dose 2 — Pfizer-BioNTech
-
2022-01-28
Dose 3 — Pfizer-BioNTech
-
2022-02-10
Survey response — day 7, dose 3MedDRA: Postmenopausal haemorrhage — Feeling: Fair · Site: Pain, Itching · Headache, Joint painsFree text: Post menopausal bleedingMedDRA releases: 2024-11 · check-in free text available
-
2022-02-13
Survey response — day 14, dose 3MedDRA: Postmenopausal haemorrhage — Feeling: FairFree text: Post menopausal bleeding a little worse.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-18
-
2022-03-04
Survey response — day 35, dose 3MedDRA: Office visit, Postmenopausal haemorrhage — Feeling: Poor · Get care from a doctor or other healthcare professionalFree text: Symptoms: Post menopausal bleeding · Healthcare visit (other): Dr. ApptMedDRA releases: 2024-11 · check-in free text available
-
2022-03-04
Report sent to call center — day 35, dose 3Get care from a doctor or other healthcare professional1 call case(s)
-
2022-03-08
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2022-03-11
Survey response — day 42, dose 3MedDRA: Haemorrhage, Hospitalisation, Surgery — Feeling: Poor · Get care from a doctor or other healthcare professionalFree text: Symptoms: Still bleeding · Healthcare visit (other): One day surgery-hospitalMedDRA releases: 2024-11 · check-in free text available
-
2022-03-11
Report sent to call center — day 42, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-03-14
-
2022-04-05
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2022-04-29
Survey response — 3 months, dose 3MedDRA: Haemorrhage, Transfusion, Uterine dilation and curettage — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Still bleeding, had a D and C, but still bleeding, had to get a blood transfusion this week, and will have another D and C on Monday. Bleeding for 80 daysMedDRA releases: 2024-11 · check-in free text available
-
2022-04-29
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Pfizer-BioNTech | No |
| 2 | 2021-03-31 | Pfizer-BioNTech | No |
| 3 | 2022-01-28 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-04 | Successful 2022-03-08 |
Reported to VAERS voluntarily prior to GDIT contact |
| 2022-03-11 | Successful 2022-04-05 |
Reported to VAERS voluntarily prior to GDIT contact |
| 2022-04-29 | Unsuccessful |
Free text
Release 11 — day 7, dose 3
Systemic reaction (other): Post menopausal bleeding
Release 11 — day 14, dose 3
Symptoms: Post menopausal bleeding a little worse.
Release 11 — day 35, dose 3
Release 11 — day 42, dose 3
Release 11 — 3 months, dose 3
Symptoms: Still bleeding, had a D and C, but still bleeding, had to get a blood transfusion this week, and will have another D and C on Monday. Bleeding for 80 days
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Hospitalisation | · | · | ✓ |
| HCVO | Office visit | · | · | ✓ |
| HCVO | Surgery | · | · | ✓ |
| SD | Haemorrhage | · | · | ✓ |
| SD | Postmenopausal haemorrhage | · | · | ✓ |
| SD | Transfusion | · | · | ✓ |
| SD | Uterine dilation and curettage | · | · | ✓ |
| SRO | Postmenopausal haemorrhage | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release